Contents

SynopsisCodesLook ForDiagnostic PearlsDifferential Diagnosis & PitfallsBest TestsManagement PearlsTherapyReferences
Primary cutaneous acral CD8+ T-cell lymphoma
Other Resources UpToDate PubMed

Primary cutaneous acral CD8+ T-cell lymphoma

Contributors: Vincent Hensperger, Susan Burgin MD
Other Resources UpToDate PubMed

Synopsis

Primary cutaneous acral CD8+ T-cell lymphoma (acral CD8+ TCL) is a rare form of cutaneous T-cell lymphoma characterized clinically by a solitary, slow-growing nodule arising most commonly on the ear. Other peripheral locations such as the nose, hands, and feet can be primary sites. Bilateral, symmetrical presentation has been reported, but multifocal presentation is rare. The solitary nodule most often lacks ulceration.

Acral CD8+ TCL typically presents in adults aged 50 and older, with a median age at diagnosis of 54. Males are more commonly affected than females.

Overall, prognosis of acral CD8+ TCL is excellent with a 5-year survival rate of 100%. It has an indolent course, and no staging investigations have shown progression to systemic disease during follow-up periods of up to 10 years.

Codes

ICD10CM:
C84.A0 – Cutaneous T-cell lymphoma, unspecified, unspecified site

SNOMEDCT:
787198005 – Primary cutaneous acral CD8 positive T-cell lymphoma

Look For

Subscription Required

Diagnostic Pearls

Subscription Required

Differential Diagnosis & Pitfalls

To perform a comparison, select diagnoses from the classic differential

Subscription Required

Best Tests

Subscription Required

Management Pearls

Subscription Required

Therapy

Subscription Required

References

Subscription Required

Last Reviewed:02/07/2022
Last Updated:02/20/2022
Copyright © 2024 VisualDx®. All rights reserved.
Primary cutaneous acral CD8+ T-cell lymphoma
Print  
A medical illustration showing key findings of Primary cutaneous acral CD8+ T-cell lymphoma : Ear, Erythema, Nose, Feet, Hands
Copyright © 2024 VisualDx®. All rights reserved.